Citations (8)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Maria-Cristina S Pranchevicius & Thiessa R Vieira. (2013) Production of recombinant immunotherapeutics for anticancer treatment. Bioengineered 4:5, pages 305-312.
Read now
Read now
Vasso Apostolopoulos. (2011) Vaccines in clinical trials: cancer. Expert Review of Vaccines 10:6, pages 711-712.
Read now
Read now
Articles from other publishers (6)
Rodney P. Rocconi, Laura Stanbery, Min Tang, Luciana Madeira da Silva, Adam Walter, Bradley J. Monk, Thomas J. Herzog, Robert L. Coleman, Luisa Manning, Gladice Wallraven, Staci Horvath, Ernest Bognar, Neil Senzer, Scott Brun & John Nemunaitis. (2022) ENTPD1/CD39 as a predictive marker of treatment response to gemogenovatucel-T as maintenance therapy in newly diagnosed ovarian cancer. Communications Medicine 2:1.
Crossref
Crossref
Mohammad Raghibul Hasan, Bader Saud Alotaibi, Sultan F. Alnomasy & Khalid Umar Fakhri. 2021. Handbook of Research on Advancements in Cancer Therapeutics. Handbook of Research on Advancements in Cancer Therapeutics
1
41
.
Maurizio Ghisoli, Minal Barve, Reva Schneider, Robert Mennel, Carl Lenarsky, Gladice Wallraven, Beena O Pappen, John LaNoue, Padmasini Kumar, Derek Nemunaitis, Alyssa Roth, James Nemunaitis, Sam Whiting, Neil Senzer, Frederick A Fletcher & John Nemunaitis. (2015) Pilot Trial of FANG Immunotherapy in Ewing's Sarcoma. Molecular Therapy 23:6, pages 1103-1109.
Crossref
Crossref
John Nemunaitis, Minal Barve, Douglas Orr, Joseph Kuhn, Mitchell Magee, Jeffrey Lamont, Cynthia Bedell, Gladice Wallraven, Beena O. Pappen, Alyssa Roth, Staci Horvath, Derek Nemunaitis, Padmasini Kumar, Phillip B. Maples & Neil Senzer. (2014) Summary of bi-shRNA<sup>furin</sup>/GM-CSF Augmented Autologous Tumor Cell Immunotherapy (FANG™) in Advanced Cancer of the Liver. Oncology 87:1, pages 21-29.
Crossref
Crossref
J Nemunaitis, N Senzer, J Olivares, P Kumar, M Barve, J Kuhn, T Nemunaitis, M Magee, Y Yu, G Wallraven, B O Pappen & P B Maples. (2013) Immune response and survival of refractory cancer patients who received TGF-β2 antisense/GM-CSF gene modified autologous tumor cell (TAG) vaccine. Gene Therapy 20:9, pages 875-879.
Crossref
Crossref
Neil Senzer, Minal Barve, Joseph Kuhn, Anton Melnyk, Peter Beitsch, Martin Lazar, Samuel Lifshitz, Mitchell Magee, Jonathan Oh, Susan W Mill, Cynthia Bedell, Candice Higgs, Padmasini Kumar, Yang Yu, Fabienne Norvell, Connor Phalon, Nicolas Taquet, Donald D Rao, Zhaohui Wang, Chris M Jay, Beena O Pappen, Gladice Wallraven, F Charles Brunicardi, David M Shanahan, Phillip B Maples & John Nemunaitis. (2012) Phase I Trial of “bi-shRNAifurin/GMCSF DNA/Autologous Tumor Cell” Vaccine (FANG) in Advanced Cancer. Molecular Therapy 20:3, pages 679-686.
Crossref
Crossref